Dementia

Son S, Speechley M, Zou G, Montero-Odasso M. Identifying the optimal combinations of modifiable dementia risk factors to target in multidomain intervention – Three-year longitudinal findings from the Canadian longitudinal study on aging. J Prev Alzheimers Dis. 2025 Aug 15:100321. doi: 10.1016/j.tjpad.2025.100321. Epub ahead of print. PMID: 40817010.

Son S, Speechley M, Zou GY, Kivipelto M, Mangialasche F, Feldman HH, Chertkow H, Belleville S, Nygaard H, Hachinski V, Pieruccini-Faria F, Montero-Odasso M. Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison. J Prev Alzheimers Dis. 2024;11(5):1490-1499. doi: 10.14283/jpad.2024.105. PMID: 39350396; PMCID: PMC11436427.

Dolatshahi Y, Mayhew A, O’Connell ME, Liu-Ambrose T, Taler V, Smith EE, Hogan DB, Kirkland S, Costa AP, Wolfson C, Raina P, Griffith L, Jones A. Prevalence and population attributable fractions of potentially modifiable risk factors for dementia in Canada: A cross-sectional analysis of the Canadian Longitudinal Study on Aging. Can J Public Health. 2024 Dec;115(6):953-963. doi: 10.17269/s41997-024-00920-7. Epub 2024 Jul 24. PMID: 39048849; PMCID: PMC11644133.

Tio ES, Hohman TJ, Milic M, Bennett DA, Felsky D; Alzheimer’s Disease Neuroimaging Initiative. Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging. J Alzheimers Dis. 2023;94(4):1549-1561. doi: 10.3233/JAD-230434. PMID: 37458040.